Correlation Between Opus Genetics, and MetaVia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Opus Genetics, and MetaVia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opus Genetics, and MetaVia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opus Genetics, and MetaVia, you can compare the effects of market volatilities on Opus Genetics, and MetaVia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opus Genetics, with a short position of MetaVia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opus Genetics, and MetaVia.

Diversification Opportunities for Opus Genetics, and MetaVia

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Opus and MetaVia is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Opus Genetics, and MetaVia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MetaVia and Opus Genetics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opus Genetics, are associated (or correlated) with MetaVia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MetaVia has no effect on the direction of Opus Genetics, i.e., Opus Genetics, and MetaVia go up and down completely randomly.

Pair Corralation between Opus Genetics, and MetaVia

Considering the 90-day investment horizon Opus Genetics, is expected to generate 1.1 times more return on investment than MetaVia. However, Opus Genetics, is 1.1 times more volatile than MetaVia. It trades about 0.01 of its potential returns per unit of risk. MetaVia is currently generating about -0.13 per unit of risk. If you would invest  126.00  in Opus Genetics, on October 1, 2024 and sell it today you would lose (8.00) from holding Opus Genetics, or give up 6.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.44%
ValuesDaily Returns

Opus Genetics,  vs.  MetaVia

 Performance 
       Timeline  
Opus Genetics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Opus Genetics, is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
MetaVia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MetaVia has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Opus Genetics, and MetaVia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Opus Genetics, and MetaVia

The main advantage of trading using opposite Opus Genetics, and MetaVia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opus Genetics, position performs unexpectedly, MetaVia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MetaVia will offset losses from the drop in MetaVia's long position.
The idea behind Opus Genetics, and MetaVia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites